Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen-reduced plasmas

Vox Sanguinis

Volumn 102, Issue 4, 2012, Pages 354-361

  Hacquard, M ^a,b,c,d   Lecompte, T ^b,c,d   Belcour, B ^a   Geschier, C ^a   Jacquot, C ^a   Jacquot, E ^a   Schneider, T ^a  

^a EFS Lorraine Champagne   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

Author keywords

ADAMTS 13; Coagulation; Endogenous thrombin potential; Hemostatic potential; Therapeutic plasma; Viro inactivation method

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; FRESH FROZEN PLASMA; THROMBIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; EVALUATION; FRANCE; HEMOSTASIS; HUMAN; PHOTOCHEMISTRY; PLASMA TRANSFUSION; PRIORITY JOURNAL; THROMBIN TIME;

ADAM PROTEINS; FACTOR VIII; FIBRINOGEN; FRANCE; HEMOSTASIS; HUMANS; PLASMA; THROMBIN;

EID: 84859837359     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01562.x     Document Type: Article

References (37)

1. Agence française de sécurité sanitaire des produits de santé. Transfusion with fresh frozen plasma (FFP): products, indications. Ann Fr Anesth Reanim 2003; 22:252-256
2. Boulat C, Clero B: Evolution of indications and consumptions of fresh frozen plasma from 1997 to 2003 in a teaching hospital. Transfus Clin Biol 2005; 12:251-256
3. Benhamou D: The use of Fresh Frozen Plasma (FFP) in 2007 in France. Transfus Clin Biol 2007; 14:557-559
4. Pelletier JPR, Transue S, Snyder EL: Pathogen inactivation techniques. Best practice and research. Best Pract Res Clin Haematol 2006; 19:205-242
5. Schneider T, Hacquard M, Lecompte T: Indications for different types of plasma in hematological diseases. Hematologie 2009; 15:1-8
6. Seghatchian J, Walker W, Reichenberg S: Updates on pathogen inactivation of plasma using Theraflex methylene blue system. Tranfus Apher Sci 2008; 38:271-280
7. Schlenke P, Hervig T, Isola H, et al. : Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers. Transfusion 2008; 48:697-705
8. Horowitz B, Lozo A, Page G, et al. : Virus inactivation by solvant/detergent and the manufacture of SD-plasma. Vox Sang 1998; 74:203-206
9. Aznar J, Bonabad S, Montoro J, et al. : Influence of methylene blue photoinactivation treatment on coagulation factors fom fresh frozen plasma, cryoprecipitates and cryosupernatants. Vox Sang 2000; 79:156-160
10. Riggert J, Humpe A, Legler T, et al. : Filtration of methylene blue-photooxidized plasma: influence on coagulation and cellular contamination. Transfusion 2001; 41:82-86
11. Garwood M, Cardigan R, Drummond O, et al. : The effect of methylene blue photoinactivation and methylene blue removal on the quality of fresh-frozen plasma. Transfusion 2003; 43:1238-1247
12. Heger A, Römisch J, Svae T: A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white light treatment. Transfus Apher Sci 2006; 35:223-233
13. Boström F, Sjödal M, Wehlin L, et al. : Coagulation parameters in apheresis and leukodepleted whole blood plasma during storage. Transfusion 2007; 47:460-463
14. Osselaer JC, Debry C, Goffaux M, et al. : Coagulation function in fresh frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Transfusion 2008; 48:108-117
15. Cid J, Ramiro L, Martinez M, et al. : Quantitative and qualitative analysis of proteins in fresh frozen plasma obtained from whole blood donations and prepared with two photochemical treatments. Transf Apher Sci 2008; 39:115-121
16. Singh Y, Sawyer L, Pinkoski L, et al. : Photochemical treatment of plasma with amotosalen and longwavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006; 46:1168-1177
17. Hemker HC, Giesen P, Al Dieri R, et al. : Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15
18. Lecompte T, Wahl D, Regnault V: Thrombinographie Hematologie 2006; 12:115-127
19. Lawrie AS, Cardigan RA, Williamson LM, et al. : The dynamics of clot formation in fresh-frozen plasma. Vox Sang 2008; 94:306-314
20. Cardigan R, Philpot K, Cookson P, et al. : Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate. Transfusion 2009; 49:696-703
21. Gerotziafas G, Depasse F, Busson J, et al. : Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay. Thromb J 2005; 3:16
22. Dargaud Y, Trzeciak MC, Bordet JC, et al. : Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost 2006; 96:562-567
23. Butenas S, van't Veer C, Mann KG: Normal thrombin generation. Blood 1999; 94:2169-2178
24. Dielis A, Castoldi E, Spronk H, et al. : Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008; 6:125-131
25. Al Dieri R, Peyvandi F, Santagostino E, et al. : The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002; 88:576-582
26. Pock K, Heger A, Janisch S, et al. : Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas). Transfus Apher Sci 2007; 37:223-231
27. Hellstern P, Haubelt H: Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy. Thromb Res 2002; 107:S3-S8
28. Lawrie AS, Harrison P, Cardigan R, et al. : The characterization and impact of microparticles on hemostasis within fresh-frozen plasma. Vox Sang 2008; 95:197-204
29. Hacquard M, Pellegrini C, Chevreux L, et al. : Microparticules procoagulantes et plasmas thérapeutiques. Transf Clin Biol 2011; 18:384
30. Lawrie AS, Green L, Canciani MT, et al. : The effect of prion reduction in solvent/detergent-treated plasma on haemostatic variables. Vox Sang 2010; 99:232-238
31. Duchemin J, Pan-Petesch B, Arnaud B, et al. : Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost 2008; 99:67-73
32. Machlus K, Colby E, Wu J, et al. : Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thromb Haemost 2009; 102:936-944
33. Flamholz R, Jeon HR, Baron JM, et al. : Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses? J Clin Apher 2000; 15:169-172
34. Depasse F, Sensebé L, Seghatchian J, et al. : The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices. Transf Apher Sci 2005; 33:63-69
35. Crettaz D, Sensebe L, Vu DH, et al. : Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filter. Proteomics 2004; 4:881-891
36. del Río-Garma J, Alvarez-Larrán A, Martínez C, et al. : Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study. Br J Haematol 2008; 143:39-45
37. Rock G, Yousef H, Neurath D, et al. : ADAMTS-13 levels in fresh, stored, and solvent detergent treated plasma. Transf Apher Sci 2006; 35:235-238